Currently, Paul J. Clancy is Chairman for Xilio Therapeutics, Inc., Independent Chairman at Sionna Therapeutics, Inc. and Secretary, Director & Vice President at Stromedix, Inc. Mr. Clancy is also on the board of Incyte Corp., EXACT Sciences Corp. and Agios Pharmaceuticals, Inc.

In the past Mr. Clancy occupied the position of Chief Financial Officer & EVP-Finance at Biogen, Inc. Chief Financial Officer & Executive Vice President of Biogen Idec New Ventures, Inc. and Senior Vice President-Finance for Biogen Idec, Inc. (North Carolina) (both are subsidiaries of Biogen, Inc.), VP & General Manager-Great West Business Unit at PepsiCo, Inc., President & Director at Bioverativ Therapeutics, Inc. and Chief Financial Officer & Executive Vice President at Alexion Pharmaceuticals, Inc.

He received an undergraduate degree from Babson College and an MBA from Columbia Business School.